ACM
AQST icon

Aquatic Capital Management’s Aquestive Therapeutics AQST Stock Holding History

Aquatic Capital Management’s Portfolio AQST Stock Details AQST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$724K Buy
174,130
+32,780
+23% +$138K 0.02% 662
2026
Q1 		$587K Buy
141,350
+117,153
+484% +$475K 0.02% 708
2025
Q4 		$156K Buy
+24,197
New +$151K ﹤0.01% 1052
2025
Q2 		– Sell
-64,909
Closed -$188K – 1235
2025
Q1 		$188K Buy
64,909
+2,297
+4% +$6.95K ﹤0.01% 948
2024
Q4 		$223K Buy
62,612
+50,112
+401% +$231K 0.01% 905
2024
Q3 		$62.3K Buy
12,500
+4,400
+54% +$17.1K ﹤0.01% 975
2024
Q2 		$21.1K Buy
+8,100
New +$27.1K ﹤0.01% 1092

Other funds holding AQST

BCM
Bratton Capital Management Fort Worth, Texas $40.8M AUM 25.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return

Aquatic Capital Management's AQST Position: Q2 2026 in Review

Aquatic Capital Management increased its Aquestive Therapeutics (AQST) stake by 23% in Q2 2026, buying an estimated $138K and bringing the position to 174,130 shares worth $724K. The position accounts for 0.02% of the portfolio, ranked #662.

Aquatic Capital Management first reported a position in AQST in Q2 2024 and has held it in 7 quarters since. 184 funds tracked by Wall St. Rank hold AQST as of Q2 2026.

  • Aquatic Capital Management held 174,130 shares of Aquestive Therapeutics worth $724K as of Q2 2026.
  • Aquatic Capital Management bought 32,780 Aquestive Therapeutics shares in Q2 2026, an estimated $138K.
  • Aquestive Therapeutics made up 0.02% of Aquatic Capital Management's portfolio in Q2 2026, its #662 holding.
  • Aquatic Capital Management first reported a position in Aquestive Therapeutics in Q2 2024 and has held it in 7 quarters since.
  • 184 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q2 2026.

Based on Aquatic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.